Today: 22 May 2026
Apple stock steady near $247 as Evercore turns bullish, Citi trims target before earnings
21 January 2026
2 mins read

Apple stock steady near $247 as Evercore turns bullish, Citi trims target before earnings

New York, Jan 21, 2026, 10:28 a.m. (EST) — Regular session

  • Apple shares held steady in morning trading as Wall Street found its footing following Tuesday’s drop
  • Evercore upgrades Apple to its “Tactical Outperform” list; Citi lowers its target, citing risks from memory costs
  • Attention turns to Apple’s Jan. 29 earnings, with a close eye on iPhone demand, profit margins, and guidance

Apple Inc (AAPL.O) shares held steady on Wednesday, closing in at $246.76 after an opening price of $248.66. During the session, the stock fluctuated between $244.85 and $248.70. The iPhone maker’s market capitalization stands around $3.01 trillion.

The timing is key. Apple will report its quarterly earnings on Jan. 29 and host a conference call at 5 p.m. ET, shining a new light on holiday iPhone sales and the company’s cost outlook.

Markets remain jittery following Tuesday’s sharp selloff, which marked the steepest one-day decline for major U.S. indexes in three months amid fresh tariff concerns linked to President Donald Trump’s bid for Greenland. “I’m not at the point yet … (this) is going to precipitate a correction,” said Jamie Cox, managing partner at Harris Financial Group. Reuters

U.S. stocks held steady Wednesday as investors digested Trump’s remarks at Davos, hoping the tough talk might ease. “We’re not going to use force to acquire Greenland… that’s a sigh of relief for markets,” said Art Hogan, chief market strategist at B Riley Wealth. Still, he cautioned that concerns linger over a potential “reigniting a trade war.” Reuters

Analysts are refocusing on iPhones and margins for Apple. Evercore ISI bumped Apple onto its “Tactical Outperform” list, signaling short-term optimism, and projected iPhone revenue to jump 17% year-over-year—well above the 11% consensus—driven by stronger demand for premium models, according to Barron’s. Meanwhile, Citi kept its Buy rating but trimmed the price target to $315 from $330, flagging a potential hit to gross margin from a forecasted 50% surge in dynamic random-access memory costs; “Apple is not totally immune from sharp memory pricing increases,” noted Citi analyst Atif Malik. Barron’s

Apple scored a legal victory this week when a federal judge in San Jose dismissed portions of a privacy class action lawsuit. The case involved data collection in Apple’s own apps and allegations related to a “pen register” tracking theory. Plaintiffs were allowed to revise some claims. courthousenews.com

Gross margin represents the portion of each sales dollar a company holds onto after covering product costs. For Apple, even a slight change can have a big impact, given the massive volume of iPhones and Macs sold, and the fact that component prices often fluctuate more quickly than retail prices.

Investors will zero in on Apple’s iPhone volume, product mix, and services growth, probing whether management expects any shifts in consumer demand following recent market swings. Margin talk will be front and center, particularly if suppliers continue raising costs for memory and other parts.

Apple’s sheer scale works in two directions. When iPhone sales impress, it moves like a pure company play. But if the mood sours on big tech, it often acts more like a stand-in for the sector’s wider trends.

The situation is complicated: a cautious outlook, tighter margins, or signs of weakening demand could all weigh on a stock investors still view as a staple. Any sudden shift in trade policy rhetoric would only deepen the uncertainty.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Energy Fuels (UUUU) stock jumps premarket as $300 million ASM deal puts rare-earth supply chain in focus
Previous Story

Energy Fuels (UUUU) stock jumps premarket as $300 million ASM deal puts rare-earth supply chain in focus

D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal
Next Story

D-Wave Quantum (QBTS) stock edges up as 10.4 million shares line up for resale after Quantum Circuits deal

Go toTop